ABL Bio Inc (298380) — Long-term Investment Intensity

Latest as of June 2019: 0.0%

ABL Bio Inc (298380) has a Long-term Investment Intensity of 0.0% as of June 2019. Long-term investments of ₩140.00 represent 0.0% of total assets of ₩162.29 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of ABL Bio Inc to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.0%
LT Investments / Total Assets

Long-term Investments

₩140.00
KRW

Total Assets

₩162.29 Billion
KRW

Country

Korea
KQ

ABL Bio Inc Long-term Investment Intensity (2017–2018)

This chart shows how ABL Bio Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of June 2019, the intensity stands at 0.0%, reflecting long-term investments of ₩140.00 against total assets of ₩162.29 Billion KRW. Explore 298380 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for ABL Bio Inc (2017–2018)

The table below presents the year-by-year Long-term Investment Intensity for ABL Bio Inc from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 298380 market cap.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2018 2.6% ₩4.37 Billion ₩168.87 Billion ▼ -39.2 pp
2017 41.8% ₩8.51 Billion ₩20.37 Billion
pp = percentage points